Funded Startups in Kangwon-do
Among the 5 most recent rounds in Kangwon-do with disclosed amounts, April Bio’s $124M (2026-06-25) is a clear outlier: it is the only disclosed round abov…
Among the 5 most recent rounds in Kangwon-do with disclosed amounts, April Bio’s $124M (2026-06-25) is a clear outlier: it is the only disclosed round above $50M, while the next-largest disclosed amount is Caring’s $27M (2026-05-08). Smaller disclosed checks cluster in the teens to high-$20s range, including NEUROPHET’s $11M (2026-04-10).
The list is also temporally concentrated: all 5 rounds fall between 2026-04-10 and 2026-06-25, with 3 closings between 2026-04-10 and 2026-05-08. Sector coverage is mixed, but “Series Unknown” appears in 3 of 5 entries (April Bio, Selectica, Elice, and NEUROPHET account for the three classifications shown; Caring is the lone Series C), alongside 2 rows marked “undisclosed” (Selectica and Elice). By geography, Gangneung appears repeatedly (Caring, Elice, NEUROPHET), indicating a local concentration around that city within this short window.
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Kangwon-do slice, and how does it compare to the other disclosed amounts?
April Bio’s $124M (2026-06-25) is the only disclosed round above $50M in the 5-row view. The next-largest disclosed amount is Caring’s $27M (2026-05-08), with NEUROPHET at $11M (2026-04-10) and the remaining disclosed amounts not exceeding that higher-$20s level.
Are there noticeable city or sector clusters in the most recent entries?
Gangneung shows up three times: Caring (2026-05-08, $27M), Elice (2026-04-13, undisclosed), and NEUROPHET (2026-04-10, $11M). Sector-wise, the entries are spread (Biotechnology, Community and Lifestyle, Education, AI, plus “Other”), with no single sector repeating across 3+ rows.
Which rounds landed in the tightest part of the timeline (roughly the last 60–70 days shown)?
From 2026-05-08 through 2026-06-25, there are two entries: Caring on 2026-05-08 ($27M) and April Bio on 2026-06-25 ($124M). The other three entries fall earlier within the window—NEUROPHET (2026-04-10, $11M), Elice (2026-04-13, undisclosed), and Selectica (2026-06-18, undisclosed).
How does stage classification break down, and does it align with the disclosed amounts?
Only one entry is labeled “Series C” (Caring, 2026-05-08, $27M). “Series Unknown” appears in 4 of 5 entries (April Bio, Selectica, Elice, NEUROPHET), and among the disclosed subset, April Bio ($124M) and Caring ($27M) are the highest disclosed amounts while Selectica and Elice are marked “undisclosed.”
Are there outliers besides the largest round—particularly around disclosure levels?
Yes: two entries are marked “undisclosed” (Selectica on 2026-06-18 and Elice on 2026-04-13), creating a disclosure split versus the disclosed amounts ($124M, $27M, and $11M). April Bio’s $124M (2026-06-25) is the standout magnitude outlier relative to the rest of the disclosed figures.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.